Beyond the Heart: Why More Interventional Cardiologists Are Treating Peripheral Artery Disease
Interventional cardiology was built around the coronary arteries. Today, a growing number of interventional cardiologists are treating vascular disease far beyond the heart.
The clinical case is established. The commercial question is who is driving the expansion.
Interventional Cardiologists
Performing selected peripheral procedures
Of Active ICs
1,625 of 5,609 physicians
Procedures Analyzed
Across four quarters
Data Through
ClearSight claims analysis
The Interventional Cardiologist Is Evolving
For decades, the specialty was largely defined by percutaneous coronary intervention. But the technical foundation of coronary practice—catheter navigation, guidewire control, angioplasty, stenting and intravascular imaging—also applies throughout the vascular system.
Training standards now reflect that broader scope. The 2023 ACC/AHA/SCAI advanced training guidance explicitly covers coronary, peripheral vascular and structural heart interventions. The ACC has also described a deliberate need to expand cardiology expertise in peripheral vascular disease, where many patients remain underdiagnosed and undertreated.
Peripheral intervention is not replacing coronary intervention. It is expanding what it means to be an interventional cardiologist.
Why Peripheral Artery Disease Demands Attention
Lower-extremity PAD affects an estimated 10–12 million people in the United States and more than 230 million worldwide. It is associated with myocardial infarction, stroke, impaired mobility, amputation and death—yet it has historically received less attention than coronary disease.
The 2024 U.S. PAD guideline emphasizes comprehensive, multidisciplinary care and recommends revascularization for appropriate patients with chronic limb-threatening ischemia or functionally limiting claudication that does not respond to medical therapy and structured exercise.
The Literature Explains Why. It Doesn’t Explain Who.
Clinical research explains why PAD matters and when intervention is appropriate. Commercial teams need a different layer of intelligence:
Looking Beyond the Literature
ClearSight analyzed activity across five selected peripheral procedure groups: BTK PTA/atherectomy, BTK stenting, visceral stenting, bypass with graft and bypass with vein. The analysis identified 1,625 interventional cardiologists with qualifying activity through Q3 2025.
Nearly One in Three ICs Shows Peripheral Activity
Among 5,609 active U.S. interventional cardiologists in ClearSight, 1,625—approximately 29%—performed at least one of the selected peripheral procedure groups.
showed activity in the selected peripheral categories.
258,784 of 385,799 selected procedures in the analysis.
Methodology note: “Peripheral activity” here is defined by the procedure groups included in this ClearSight analysis. It should not be interpreted as board certification or a dedicated peripheral subspecialty designation.
The Procedure Mix Is Heavily Weighted Toward Below-the-Knee Care
High-Volume Peripheral Facilities
The facilities with the highest selected procedure activity span major academic and regional health systems across the country.
| Facility | City, State |
|---|---|
| Mount Sinai Hospital | Brooklyn, NY |
| Methodist Healthcare – Memphis Hospitals | Memphis, TN |
| Tallahassee Memorial Healthcare INC | Tallahassee, FL |
| Banner – University Medical Center Phoenix | Phoenix, AZ |
| The Cleveland Clinic Foundation | Cleveland, OH |
| Adventhealth Orlando | Orlando, FL |
| HCA Florida Memorial Hospital | Jacksonville, FL |
| Rex Hospital | Apex, NC |
| Strong Memorial Hospital | Rochester, NY |
| The Moses H. Cone Memorial Hospital Operating Corporation | Greensboro, NC |
Facility names open the corresponding ClearSight platform profile in a new tab.
The Physicians Leading Peripheral Activity
The physician landscape is geographically distributed, but a clear group of high-activity interventional cardiologists emerges from the selected categories.
| Physician | City, State |
|---|---|
| Dr. Jason Yoho | Lafayette, LA |
| Dr. Vinod Chainani | Miami, FL |
| Dr. Mohannad Bisharat | Jacksonville, FL |
| Dr. Prakash Krishnan | Brooklyn, NY |
| Dr. Yazan Khatib | Jacksonville, FL |
| Dr. Matthew Comstock | Tulsa, OK |
| Dr. Jonathan Bonilla | Lafayette, LA |
| Dr. Farah Al Khitan | Jacksonville, FL |
| Dr. James Joye | Salinas, CA |
| Dr. Samir Hadeed | Davidsville, PA |
Physician names open the corresponding ClearSight platform profile in a new tab.
Hospitals Still Anchor Peripheral Care
In Q3 2025, hospitals accounted for 79,211 selected procedures, compared with 8,165 in office-based labs and 2,792 in ambulatory surgery centers. Outpatient settings are meaningful, but the selected mix remains predominantly hospital-based.
Beyond the Coronary Arteries
The expansion of interventional cardiology into peripheral disease is no longer theoretical. It is visible in training standards, clinical practice and real-world physician activity.
The commercial opportunity is not simply to understand that the specialty is changing. It is to identify the physicians, facilities and markets leading that change before everyone else does.
References
- ACC, AHA and SCAI Release New Training Guidance for Interventional Cardiology.
- 2024 ACC/AHA Guideline for the Management of Lower Extremity Peripheral Artery Disease.
- ACC: PAD—Putting the 2024 Guideline Into Practice.
- ACC: Expanding the Cardiologist’s Lens—The Urgency of PAD.
- ClearSight Health Commercial Intelligence Platform. Analysis of selected U.S. peripheral procedure groups involving 1,625 interventional cardiologists; data through Q3 2025.
